Global Laxative Market, By Type (Osmotic Laxatives, Stimulant Laxatives, Bulk Laxatives, and Lubricant and Emollient Laxatives), Flavors (With Flavor and Without Flavor), Source (Natural, Synthetic, and Others), Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced Constipation, Acute Constipation, and Others), Mode of Purchase (Prescription, and Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid, Gels, Suppositories, and Others), Route of Administration (Oral, and Rectal), Population Type (Children, and Adults), Sales Channel (Hospitals, Elderly Care Centers, Laxative, Pharmacy Stores, Health and Beauty Stores, and Others), Distribution channel (Direct Sales, Wholesalers, and Others) – Industry Trends and Forecast to 2031.
Laxative Market Analysis and Size
In the laxative market, continual advancement in formulations and delivery methods brings substantial benefits. Enhanced efficacy, reduced side effects, and improved convenience contribute to better patient compliance and satisfaction. This progress fosters a healthier approach to gastrointestinal wellness, catering to diverse needs and preferences, ultimately elevating the overall standard of care.
Data Bridge Market Research analyses that the global laxative market size was valued at USD 6.91 billion in 2023, is projected to reach USD 11.26 billion by 2031, with a CAGR of 6.3% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016 - 2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Osmotic Laxatives, Stimulant Laxatives, Bulk Laxatives, and Lubricant and Emollient Laxatives), Flavors (With Flavor and Without Flavor), Source (Natural, Synthetic and Others), Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced Constipation, Acute Constipation, and Others), Mode of Purchase (Prescription and Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid, Gels, Suppositories, and Others), Route of Administration (Oral and Rectal), Population Type (Children and Adults), Sales Channel (Hospitals, Elderly Care Centers, Laxative, Pharmacy Stores, Health and Beauty Stores, and Others), Distribution channel (Direct Sales, Wholesalers, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Johnson & Johnson Services, Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy's Laboratories Ltd. (India), Lupin (India), Fresenius Kabi AG (Germany), Aurobindo Pharma (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc. (Canada), and Eli Lilly and Company (U.S.)
|
|
Market Opportunities
|
|
Market Definition
A laxative is a substance that promotes bowel movements and relieves constipation by stimulating the intestines or softening stool. Laxatives, offered in pills, liquids, or suppositories, work by increasing colon fluid or stimulating muscle movement to propel waste through the digestive system. Their usage should be cautious and under medical supervision for optimal effectiveness and safety.
Laxative Market Dynamics
Drivers
- Increasing Prevalence of Gastrointestinal Disorders
The laxative market is propelled by the increasing prevalence of gastrointestinal disorders such as constipation and irritable bowel syndrome (IBS). For instance, as more individuals adopt sedentary lifestyles and consume processed foods low in fiber, constipation rates rise. Consequently, a heightened demand for laxatives is needed to manage these symptoms effectively. This trend underscores the necessity for accessible and effective treatment options to address the growing burden of gastrointestinal issues.
- Expanding Geriatric Population
The growing elderly population in developed nations fuels laxative demand, given age-related bowel function changes. Elderly individuals face increased susceptibility to constipation and gastrointestinal issues, prompting the need for laxative usage. This demographic shift underscores the necessity for effective bowel health management strategies to address the unique needs of aging populations in maintaining digestive wellness.
Opportunities
- Increasing Healthcare Expenditure
Rising healthcare expenditure, especially in emerging economies, boosts access to healthcare services and medications such as laxatives. This facilitates greater affordability and availability of laxative products, driving market growth. As investment in healthcare infrastructure and services increases, individuals in these regions can access essential medications more readily, addressing gastrointestinal issues and contributing to market expansion.
- Changing Dietary Habits and Sedentary Lifestyles
Modern lifestyles marked by poor diets, low fiber intake, insufficient hydration, and sedentary habits contribute to constipation. Consequently, there's an increased demand for laxatives to address associated symptoms. For instance, diets lacking in fruits, vegetables, whole grains, and prolonged sitting can slow bowel movements. This leads individuals to seek relief through laxatives, highlighting the market's reliance on lifestyle-induced digestive issues for growth.
Restraints/Challenges
- Side Effects and Tolerance
Laxatives carry side effects such as abdominal cramps, diarrhea, and dehydration. Prolonged use often results in tolerance, demanding higher doses for effectiveness. These adverse effects, coupled with the demand for escalating doses, may deter consumers from prolonged usage, impacting the market negatively. As a result, there is a growing interest in alternative solutions with fewer side effects within the laxatives market.
- Competition from Natural Remedies
The laxative market faces stiff competition from the growing popularity of natural remedies and alternative therapies for digestive health. Consumers are increasingly drawn to gentler, non-pharmacological solutions, leading to a shift in demand away from traditional laxatives. This trend reflects a broader preference for holistic approaches to wellness, challenging the market's reliance on conventional pharmaceutical products.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2022, Roivant Sciences, in collaboration with Pfizer, launched RVT-3101 to tackle ulcerative colitis. Roivant retains commercial rights in the U.S. and Japan, while Pfizer oversees commercialization elsewhere. This partnership aims to combat the global impact of ulcerative colitis through joint commercial efforts
- In 2022, JB Pharma unveiled Ranraft, a novel treatment for gastroesophageal reflux disease (GERD), bolstering its position in gastroenterology. This strategic launch expands JB Pharma's product portfolio and underscores its dedication to innovative digestive health solutions, catering to the needs of GERD sufferers
- In 2021, Purdue Pharma L.P. introduced two Senokot Dietary Supplement Products. Senokot Laxative Gummies, in blueberry pomegranate flavor, offer gentle overnight relief for constipation with natural senna extract. Senokot Laxative Tea, infused with cinnamon and floral notes, diversifies their digestive health offerings
- In 2020, FDA approved lactitol for chronic idiopathic constipation treatment in adults. As a powder, lactitol offers flexibility in administration and is easily mixed with water or juice for enhanced patient convenience. This approval broadens treatment options, providing a versatile solution for chronic constipation sufferers
Laxative Market Scope
The market is segmented on the basis of type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Osmotic Laxatives
- Stimulant Laxatives
- Bulk Laxatives
- Lubricant and Emollient Laxatives
Flavors
- With Flavor
- Without Flavor
Source
- Natural
- Synthetic
- Others
Indication
- Chronic Constipation
- Irritable Bowel Syndrome with Constipation
- Opioid-Induced Constipation
- Acute Constipation
- Others
Mode of Purchase
- Prescription
- Over-the-Counter
Dosage Form
- Tablets
- Capsules
- Powder
- Liquid
- Gels
- Suppositories
- Others
Route of Administration
- Oral
- Rectal
Population Type
- Children
- Adults
Sales Channel
- Hospitals
- Elderly Care Centers
- Laxative
- Pharmacy Stores
- Health and Beauty Stores
- Others
Distribution channel
- Direct Sales
- Wholesalers
- Others
Laxative Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel, and distribution channel as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
North America is expected to dominate the global laxative market in terms of both market share and revenue, fueled by rising usage and healthcare spending. The region's growth is driven by major players and the adoption of advanced technologies, ensuring continued dominance in the forecast period.
Asia-Pacific is expected to be the fastest-growing region in the global laxative market, driven by increasing investment in innovative research and development for novel drug products. Additionally, developing healthcare infrastructure and the rising number of generic drug manufacturers will further propel growth in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Laxative Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Merck & Co., Inc. (U.S.)
- AstraZeneca (U.K.)
- Johnson & Johnson Services, Inc. (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Dr. Reddy's Laboratories Ltd. (India)
- Lupin (India)
- Fresenius Kabi AG (Germany)
- Aurobindo Pharma (India)
- Cipla Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Amneal Pharmaceuticals LLC. (U.S.)
- Apotex Inc. (Canada)
- Eli Lilly and Company (U.S.)
SKU-